Page last updated: 2024-08-21

diphenylamine and Atypical Lipomatous Tumor

diphenylamine has been researched along with Atypical Lipomatous Tumor in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bekki, H; Ishii, T; Iura, K; Iwamoto, Y; Kawashima, H; Kohashi, K; Maekawa, A; Nabeshima, K; Oda, Y; Yamada, Y; Yamamoto, H	1

Other Studies

1 other study(ies) available for diphenylamine and Atypical Lipomatous Tumor

Article	Year
Activation of the Akt-mTOR and MAPK pathways in dedifferentiated liposarcomas. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016, Volume: 37, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Cell Line, Tumor; Cell Proliferation; Diphenylamine; Drug Synergism; Everolimus; Female; Humans; Inhibitory Concentration 50; Liposarcoma; Male; MAP Kinase Signaling System; Middle Aged; TOR Serine-Threonine Kinases	2016

Article

Year

Activation of the Akt-mTOR and MAPK pathways in dedifferentiated liposarcomas.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016, Volume: 37, Issue:4

Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Cell Line, Tumor; Cell Proliferation; Diphenylamine; Drug Synergism; Everolimus; Female; Humans; Inhibitory Concentration 50; Liposarcoma; Male; MAP Kinase Signaling System; Middle Aged; TOR Serine-Threonine Kinases

2016